Cardiac Monitoring Devices Market : Emerging Market Trends, Opportunities and Business Insights

Cardiac Monitoring Devices Market : Emerging Market Trends, Opportunities and Business Insights

Cardiac monitoring refers to the continuous monitoring of heart activities by cardiac monitoring devices such as electrocardiograms, recording devices, and visual and/or audible recorders. These devices are used to either identify or rule out a heart rhythm disorder and determine the right course of treatment. Cardiac rhythm management devices include implantable devices (defibrillators and pacemakers), leads, and external devices to treat and manage arrhythmia-related diseases. The growth of this cardiac monitoring devices market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM CRM devices; and the growing preference for wearable cardiac devices.

According to research report the global cardiac monitoring devices market size is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55

  • On the basis of cardiac rhythm management devices by type, the market is segmented into defibrillators and pacemakers. In 2019, the defibrillators segment accounted for the largest market share. This segment is also projected to register the highest CAGR during the forecast period. Factors such as technological advancements in defibrillators, rising prevalence of CVD, and growing focus on providing public-access defibrillators are driving the growth of this market.
  • On the basis of cardiac monitoring devices by type, the market is segmented into ECG devices, event monitors, implantable loop recorders (ILRs), cardiac output monitoring (COM) devices, mobile cardiac telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG devices segment accounted for the largest share of the cardiac monitoring devices market. The large share of this segment can be attributed to technological advancements such as the incorporation of advanced algorithms and workflow improvement features, such as simplified operations, touchscreen systems, portability, wireless features, and better connectivity with cardiovascular information systems (CVIS), electronic medical records (EMRs), and ECG management systems.
  • On the basis of region, the cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cardiac monitoring market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

The cardiac monitoring devices market is a highly fragmented market and is dominated by various players. The major players operating in this market are Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl (Italy).

Medtronic (Ireland)

Medtronic is one of the leading companies in the cardiac monitoring and cardiac rhythm management devices market. In order to maintain its position, Medtronic continuously focuses on gaining approvals for its advanced products in this market. Between 2017 and 2020, the company received approval for various cardiac devices, such as pacemakers and defibrillators. Medtronic operates in more than 160 countries across North America, Western Europe, Asia, and Latin America.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com